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Endometrial cancer is the most common invasive cancer of the female
genital tract, with an increasing incidence rate. Abnormal uterine bleed-
ing is the presenting symptom in 75-90% of cases [1, 2]. The majority of
patients with endometrial cancer are diagnosed with no evidence of extra-
uterine spread (70-80% stage I), which gives patients better prognosis 
[1, 3]. In more advanced disease the sites commonly affected outside the
uterus are pelvic and para-aortic lymph nodes and the ovaries [4]. Simi-
larly to uterine sarcomas, distant metastases in advanced or recurrent
endometrial cancer most commonly involve the lungs, liver, central nerv-
ous system and skin [4-6]. 
Metastases to bones have been described in 2-15% of patients with
metastatic disease, and the most common site of osseous metastases are
vertebrae, with pelvic bones, ribs and sternum [3, 7]. Isolated metastases
to bone extremities are extremely rare, and thought to result from the
haematological spread of cancer cells [5]. The review of the Medline data-
base by searching the items endometrial cancer and metastases to extrem-
ities showed twenty such cases, with only nine cases when metastatic
tumour of the foot was the first manifestation of endometrial cancer 
(Table I) [3, 5, 7-13]. 
A 74-year-old female suffered from pain and swelling of the right foot
from October 2006. In the X-ray picture and bone scintigraphy, sus-
pected lesion of the right calcaneus, talus and metatarsal bones was
detected (Figure 1). Afterwards it was histologically verified in the biop-
sy as metastatic cancer (Figure 2). The patient had no vaginal bleeding
or other gynaecological symptoms, but subsequent computed tomog-
raphy scans showed an enlarged uterus. Uterine curettage confirmed
the diagnosis of endometrial cancer. The patient was treated with total
abdominal hysterectomy, bilateral salpingo-oophorectomy without pelvic
lymph node dissection in December 2006. The histological diagnosis
was a moderate differentiated (G2) endo  metrioid endometrial cancer
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invading the outer half of the myometrium (> 1/2)
with invasion of cervical stroma. The fallopian
tubes and the ovaries showed no signs of metas-
tases. No evidence of macroscopic abdo  mino  -
pelvic metastases was found at surgery. Her dis-
ease was classified as clinical stage IVB according
to FIGO 2009 staging, but in the TNM classifica-
tion it was pT2 Nx M2. 
In January 2007 the patient was admitted to the
department of palliative radiotherapy. She received
irradiation by Co 60 until a total dose of 20 Gy to
the tumour of the right foot, with complete resolu-
tion of symptoms. The patient was discharged from
hospital in March 2007. During the observation from
surgery in December 2006 until June 2010 no other
metastases were detected. The patient remains alive
Author/year Age  Histology Grade Bone  Other  Treatment Survival
(references) [years] involved metastasis [months]
Vanecko RM,  54 – – Fibula – – –
et al./1967 [10]
Onuba O/1983 [13] 57 Endometrioid  – Tibia Lung,  – –
adenocarcinoma kidney
Cooper JK,  59 Endometrioid  2 Calcaneus No Chemotherapy,  > 60
et al./1994 [7] adenocarcinoma radiotherapy
Petru E,  61 Endometrioid  1 Tarsus No Chemotherapy,  10
et al./1995 [11] adenocarcinoma hormone therapy
Malicky ES,  44 Endometrioid  2 Femur No Radiotherapy,  > 12
et al./1997 [12] adenocarcinoma hormone therapy
Manolitsas TP,  76 Endometrioid  3 Calcaneus No Radiotherapy 20
et al./2002 [3] adenocarcinoma
Uharcek P,  67 Endometrioid  1 Calcaneus, talus  No Surgery,  > 20
et al./2006 [8] adenocarcinoma and metatarsal  chemotherapy, 
bones hormone therapy
Loizzi V,  73 Endometrioid  3 Tibia No Chemotherapy 9
et al. 2006 [5] adenocarcinoma
Kaya A,  70 Endometrioid  1 Tibia No Radiotherapy > 47
et al./2007 [9] adenocarcinoma
This case, 2010 74 Endometrioid  2 Calcaneus, talus  No Radiotherapy > 40
adenocarcinoma and metatarsal 
bones
Table I. Isolated metastasis to the bones of the extremities as the first manifestation of endometrial cancer – review
of the literature
Figure 2. Metastatic endometrial cancer cells in the
fine needle aspiration of the tumour of the foot 
(H + E, 200× magnification)
Figure 1. Radiograph of the right foot demonstrating
metastases of the endometrial cancer
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and asymptomatic 43 months after the diagnosis
of metastatic endometrial cancer to the foot.
Our report presented in the previous section has
three main peculiar features: 1) it demonstrates
endometrial cancer that presented with osseous
metastasis, which is a rare occurrence, 2) the
metastatic tumour was located in the foot, which
is extremely rare, 3) the bone lesion was a single
bone metastasis, which is unusual in such cases.
Additionally, the case in which isolated metastatic
tumour of the extremity was the first manifesta-
tion of endometrial cancer is the tenth such case
reported in the literature (Table I), and the second
one located in the calcaneus and involving talus
and metatarsal bones [8]. 
Despite the rarity of metastases to the upper
and lower extremities, there is a need to have
a high index of suspicion for metastasis in patients
with a history of endometrial cancer who present
with swelling or bony tenderness. The initial diag-
nosis can be challenging, as the symptoms of pain
and swelling are often attributed to other more
common benign conditions such as soft tissue
inflammation, trauma, arthritis, and osteomyelitis
[7]. It is important to consider bone metastasis as
a possible diagnosis also in patients without his-
tory of cancer, but with osseous pain not respond-
ing to conservative treatment [5, 9-13]. Appropriate
imaging may include plain X-ray picture and
radionuclide bone scans [3]. Technetium diphos-
phonate bone scans can be positive up to 18
months before a lesion is detectable on plain X-ray
[14]. Therefore, a biopsy should be performed in
patients with suspected lesions, and who demon-
strate evidence of bony destruction [4].
The treatment strategy in patients with con-
firmed isolated metastatic lesion in the bone
extremity still remains a topic of controversy,
because of the few descriptions available in the lit-
erature and the different bone sites involved. For
these reasons, a common suitable treatment regi-
men cannot be established and treatment should
be tailor suited to each patient. The treatment of
irradiation with or without surgery, hormone ther-
apy and chemotherapy is reported as effective in
most cases and may be curative [4, 5, 7, 9, 11, 12].
The main goal of treatment should be to eliminate
or palliate pain and prolong survival.
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